Efficacy of Stereotactic Body Radiotherapy for Recurrent or Residual Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization.
Erhua YaoJinghong ChenXiaofang ZhaoYinyan ZhengXianheng WuFei HanHecheng HuangPing LiangJianmin LiuFasheng WuLianxing LinPublished in: BioMed research international (2018)
SBRT is a promising noninvasive and palliative treatment with acceptable toxicity for recurrent or residual HCC after TACE.